Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma – An analysis of the prospective skin cancer registry ADOREGCorinna Kochanek, Ralf Gutzmer, Catharina Gilde et al.|European Journal of Cancer|2023Cited by 7
First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREGSören Reinhard, Henner Stege, Jochen Utikal et al.|European Journal of Cancer|2025Cited by 4
Epidemiology of patch tested patients with permanent tattoos—A comparative analysis of 9693 IVDK patients (2020–2022)Steffen Schubert, Richard Brans, Nicola Wagner et al.|Contact Dermatitis|2024Cited by 1
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant MelanomaMichael Weichenthal, Dirk Schadendorf, Dirk Debus et al.|Cancers|2026Cited by 0